RSS Feed Print Category View
Simeprevir Earns Positive Internal Review from FDA
ThomasKim
Posted: Tuesday, October 22, 2013 1:33 PM
Joined: 2/20/2013
Posts: 39


"Johnson & Johnson and its partner Medivir took another big step toward the booming hepatitis C market today, earning a positive internal review at the FDA for simeprevir. But analysts concluded that a substantial subpopulation of patients infected with a particular polymorphism variant won't likely benefit from the NS3/4A protease inhibitor, leaving that field open to some big rivals contending for near-term approvals."

To read more, please visit: http://www.fiercebiotech.com/story/fda-gives-jj-thumbs-catch-hep-c-drug-simeprevir/2013-10-22?utm_medium=nl&utm_source=internal